GAA and type 2 diabetes mellitus: Here, analysing faecal samples from a randomised, placebo-controlled clinical study involving patients with metformin-treated T2D, we show that 14 days of treatment with the alpha-glucosidase inhibitor acarbose, known to increase the amount of undigested and complex carbohydrates in the distal parts of the gut, shows only minor effects on the GM composition.